Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Schizophrenia Research|June 15, 2007
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis useF Markus Leweke, Andrea Giuffrida, Dagmar Koethe, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 21, 2013
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disordersCarola Schaefer, Frank Enning, Juliane K Mueller, et al.
Plos Medicine|August 29, 2006
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophreniaElaine Holmes, Tsz M Tsang, Jeffrey T-J Huang, et al.
Plos Medicine|November 9, 2006
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosisJeffrey T-J Huang, F Markus Leweke, David Oxley, et al.
Plos One|December 20, 2012
Molecular sex differences in human serumJordan M Ramsey, Emanuel Schwarz, Paul C Guest, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 25, 2014
Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processingDavide Rivolta, Nazareth P Castellanos, Cerisa Stawowsky, et al.
Psychoneuroendocrinology|January 22, 2011
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophreniaPaul C Guest, Emanuel Schwarz, Divya Krishnamurthy, et al.
Schizophrenia Research|March 27, 2012
Gastrointestinal inflammation and associated immune activation in schizophreniaEmily G Severance, Armin Alaedini, Shuojia Yang, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
Scientific Reports|February 22, 2024
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipidsMichael Allwright, Boris Guennewig, Anna E Hoffmann, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Schizophrenia Research|June 15, 2007
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis useF Markus Leweke, Andrea Giuffrida, Dagmar Koethe, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 21, 2013
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disordersCarola Schaefer, Frank Enning, Juliane K Mueller, et al.
Plos Medicine|August 29, 2006
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophreniaElaine Holmes, Tsz M Tsang, Jeffrey T-J Huang, et al.
Plos Medicine|November 9, 2006
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosisJeffrey T-J Huang, F Markus Leweke, David Oxley, et al.
Plos One|December 20, 2012
Molecular sex differences in human serumJordan M Ramsey, Emanuel Schwarz, Paul C Guest, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 25, 2014
Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processingDavide Rivolta, Nazareth P Castellanos, Cerisa Stawowsky, et al.
Psychoneuroendocrinology|January 22, 2011
Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophreniaPaul C Guest, Emanuel Schwarz, Divya Krishnamurthy, et al.
Schizophrenia Research|March 27, 2012
Gastrointestinal inflammation and associated immune activation in schizophreniaEmily G Severance, Armin Alaedini, Shuojia Yang, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
Scientific Reports|February 22, 2024
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipidsMichael Allwright, Boris Guennewig, Anna E Hoffmann, et al.
Pageof 12